Mozart Therapeutics
Regulatory CD8 T cells | Autoimmune and Inflammatory diseases
United States · $80.0M raised
- Website
- mozart-tx.com
- Total Funding
- $80.0M
- Last Round
- $25.0M Extension RoundJun 2023
- Rounds
- 2
About
Clinical-stage biopharmaceutical company developing disease-modifying therapies that restore healthy immune system function to treat autoimmune and inflammatory diseases.
Summary
Mozart Therapeutics is a Biotech company based in United States. It has raised $80.0M in total across 2 rounds, most recently a $25.0M Extension Round round in Jun 2023. Investors include ARCH Venture Partners, Sofinnova Partners and UPMC Enterprises.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mozart-therapeutics"><img src="https://indexed.vc/api/badge/company/mozart-therapeutics" alt="Mozart Therapeutics on Indexed.vc" width="260" height="76" /></a>